Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Directorate Change

18 Apr 2016 07:00

RNS Number : 3904V
Scapa Group PLC
18 April 2016
 

18 April 2016

Scapa Group plc

('Scapa' or 'the Company')

 

Directorate Change

 

Scapa Group plc (AIM: SCPA), a global manufacturer of bonding materials and solutions for the Healthcare and Industrial markets, announces the following directorate changes.

Non-Executive Directors

David Blackwood has been appointed to the Board as an independent Non-Executive Director. He will join the Board on 1 May 2016 and chair the Audit and Risk Committee from 1 June 2016. Mr Blackwood is a Non-Executive Director of Dignity Plc and was previously Group Finance Director of Synthomer plc, a position from which he retired in May 2015. Prior to that, he was Group Treasurer at Imperial Chemical Industries plc ("ICI") and held a number of senior positions with ICI over a period of 22 years. He is a Chartered Accountant and a Fellow of the Association of Corporate Treasurers.

As a Non-Executive Director of Scapa, Mr Blackwood will sit on the Company's Remuneration Committee and Nominations Committee. 

Mike Buzzacott will retire from his role as Non-Executive Director and Chairman of the Audit and Risk Committee on 30 May 2016. 

James Wallace, Chairman of the Board, commented: "The Board thanks Mike for his contribution to the Board over the last eight years. We are pleased to welcome David to the Board and look forward to leveraging the wealth of experience he brings to the role."

Composition of Board Committees

The following table sets out the composition of the Board Committees effective 1 June 2016:

Committee

Chairman

Members

Audit and Risk

David Blackwood

Martin Sawkins

Richard Perry

James Wallace

 

Nominations

James Wallace

David Blackwood

Martin Sawkins

Richard Perry

 

Remuneration

Martin Sawkins

David Blackwood

Richard Perry

James Wallace

 

The Company makes the following disclosures in relation to Mr Blackwood's appointment in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies:

1. Director's full name: David Charles Blackwood

Director's age: 57 years

2. Other directorships / partnerships held during the last five years, including appointment and resignation dates:

Name of Company / Partnership

Date appointed

Date resigned

 

 

 

Dignity Plc

01/10/2015

n/a

 

Polymerlatex Limited

31/03/2011

 

01/05/2015

Synthomer plc

01/10/2007

01/05/2015

 

Synthomer Holdings Limited

29/11/2012

01/05/2015

 

Synthomer sprl

 

01/11/2011

01/06/2015

Synthomer (UK) Limited

30/11/2012

30/07/2015

 

 

3. Other information: there is no other information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

 

Enquiries:

Rebecca Smith, Company Secretary Tel: 0161 301 7430

Scapa Group plc

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASFDFDIFMSEDL
Date   Source Headline
2nd Jul 20184:33 pmRNSTotal Voting Rights
28th Jun 20184:12 pmRNSDirector/PDMR Shareholding
5th Jun 20184:00 pmRNSDirector/PDMR Shareholding
31st May 201810:31 amRNSTotal Voting Rights
30th May 201810:20 amRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSFinal Results
30th Apr 201810:30 amRNSTotal Voting Rights
12th Apr 20187:00 amRNSTrading Statement
11th Apr 20183:29 pmRNSIncident at Dunstable Site
29th Mar 201811:48 amRNSTotal Voting Rights
26th Mar 20187:00 amRNSAcquisition
28th Feb 20181:38 pmRNSTotal Voting Rights
7th Feb 20189:17 amRNSBlock listing Interim Review
31st Jan 20189:08 amRNSTotal Voting Rights
25th Jan 20182:14 pmRNSBlock listing Interim Review
8th Jan 201810:10 amRNSDirectorate Change
7th Dec 20173:52 pmRNSDirector/PDMR Shareholding
7th Dec 20173:49 pmRNSAdditional Listing
29th Nov 201711:15 amRNSDirector/PDMR Shareholding
28th Nov 20172:56 pmRNSDirector/PDMR Shareholding
28th Nov 20172:44 pmRNSDirector/PDMR Shareholding
23rd Nov 20179:36 amRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf-year Report
17th Nov 201710:22 amRNSAdditional Listing
11th Oct 20177:00 amRNSTrading Statement
4th Oct 20177:00 amRNSCapital Markets Day
26th Sep 201711:38 amRNSAdditional Listing
21st Sep 20174:21 pmRNSHolding(s) in Company
8th Sep 201711:31 amRNSDirector/PDMR Shareholding
4th Sep 20173:18 pmRNSDirector/PDMR Shareholding
4th Sep 201710:13 amRNSAdditional Listing
25th Aug 20177:00 amRNSDirector/PDMR Shareholding
17th Aug 20174:14 pmRNSDirector/PDMR Shareholding
11th Aug 20174:12 pmRNSDirector/PDMR Shareholding
9th Aug 20177:00 amRNSAcquisition
7th Aug 20171:56 pmRNSBlock listing Interim Review
25th Jul 201710:09 amRNSBlock listing Interim Review
19th Jul 20179:29 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSAGM Statement
1st Jun 20171:59 pmRNSHolding(s) in Company
30th May 20172:09 pmRNSAdditional Listing
23rd May 20177:00 amRNSFinal Results
18th May 20173:47 pmRNSHolding(s) in Company
17th May 20173:36 pmRNSHolding(s) in Company
3rd May 201710:31 amRNSAdditional Listing
21st Apr 20179:41 amRNSHolding(s) in Company
19th Apr 20173:33 pmRNSAdditional Listing
13th Apr 20177:00 amRNSTrading Statement
27th Mar 20172:05 pmRNSDirector/PDMR Shareholding
23rd Mar 201711:46 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.